| Kristine Janell Paluska, OD | |
|
1309 Liberty St Se, Salem, OR 97302-4245 | |
| (503) 585-2022 | |
| (503) 378-0797 |
| Full Name | Kristine Janell Paluska |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 1309 Liberty St Se, Salem, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225396229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3098ATI (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristine Janell Paluska, OD 1309 Liberty St Se, Salem, OR 97302-4245 Ph: (503) 585-2022 | Kristine Janell Paluska, OD 1309 Liberty St Se, Salem, OR 97302-4245 Ph: (503) 585-2022 |
News Archive
President Barack Obama said Wednesday that he will only compromise on the federal budget - including addressing long-term Medicare and Medicaid costs - after Republicans agree to reopen the federal government without changing the health law. Republicans may shift their focus to these budget battles and seek savings in entitlement programs and tax reform.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.
Evidence continues to mount that exercise provides many benefits to help people look and feel younger. The March issue of Mayo Clinic Women's HealthSource offers a recap of the many benefits of regular exercise.
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.
In recent years, immunotherapy has emerged as a promising treatment for certain cancers. Now this strategy, which uses patients' own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
› Verified 8 days ago
Eye Focus Northwest Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3816 Center St Ne, Salem, OR 97301 Phone: 503-588-5513 Fax: 503-588-5470 | |
Dr. Robert M Paluska, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1309 Liberty St Se, Salem, OR 97302 Phone: 503-585-2022 Fax: 503-378-0797 | |
Family Focus Vision Source Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3400 State St, #g-770, Salem, OR 97301 Phone: 503-585-6700 Fax: 503-585-3315 | |
Heather Mellen Jensen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5125 Skyline Rd S, Salem, OR 97306 Phone: 503-361-5400 | |
Karen Elaine Cahill, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr. Ne, Salem, OR 97305 Phone: 503-316-2340 | |
Dr. Jordan David Brown, D.O. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1097 Liberty St Se, Salem, OR 97302 Phone: 503-581-4411 Fax: 503-581-4411 | |
Michael D Klautzsch Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1810 Summer St Ne, Salem, OR 97301 Phone: 503-364-0767 Fax: 503-581-8340 |